TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection.

[1]  B. Hahn,et al.  A Novel CCR5 Mutation Common in Sooty Mangabeys Reveals SIVsmm Infection of CCR5-Null Natural Hosts and Efficient Alternative Coreceptor Use In Vivo , 2010, PLoS pathogens.

[2]  D. Watkins,et al.  Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies , 2010, Nature Protocols.

[3]  J. Lifson,et al.  Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-Derived Autologous Simian Immunodeficiency Virus-Specific CD8+ T Cell Clones in Rhesus Macaques during Acute Infection , 2009, The Journal of Immunology.

[4]  J. Corbeil,et al.  Nonpathogenesis of Simian Immunodeficiency Virus Infection Is Associated with Reduced Inflammation and Recruitment of Plasmacytoid Dendritic Cells to Lymph Nodes, Not to Lack of an Interferon Type I Response, during the Acute Phase , 2009, Journal of Virology.

[5]  M. Piatak,et al.  Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses. , 2009, Virology.

[6]  J. Hoxie,et al.  Derivation and Characterization of a Simian Immunodeficiency Virus SIVmac239 Variant with Tropism for CXCR4 , 2009, Journal of Virology.

[7]  L. Picker,et al.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, The Journal of experimental medicine.

[8]  J. Petravic,et al.  Is the Gut the Major Source of Virus in Early Simian Immunodeficiency Virus Infection? , 2009, Journal of Virology.

[9]  R. Kutner,et al.  Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors , 2009, Nature Protocols.

[10]  J. Zack,et al.  Differentially Stimulated CD4+ T Cells Display Altered Human Immunodeficiency Virus Infection Kinetics: Implications for the Efficacy of Antiviral Agents , 2009, Journal of Virology.

[11]  Shawn O'Neil,et al.  Differential CD4+ T-Lymphocyte Apoptosis and Bystander T-Cell Activation in Rhesus Macaques and Sooty Mangabeys during Acute Simian Immunodeficiency Virus Infection , 2008, Journal of Virology.

[12]  H. Jessen,et al.  CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual , 2008, PloS one.

[13]  J. Orange,et al.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.

[14]  J. Lifson,et al.  Efficient inhibition of SIV replication in rhesus CD4+ T-cell clones by autologous immortalized SIV-specific CD8+ T-cell clones. , 2008, Virology.

[15]  J. Altman,et al.  IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+ T Cell Responses1 , 2008, The Journal of Immunology.

[16]  J. Lifson,et al.  Comparison of Plasma Viremia and Antibody Responses in Macaques Inoculated with Envelope Variants of Single-Cycle Simian Immunodeficiency Virus Differing in Infectivity and Cellular Tropism , 2007, Journal of Virology.

[17]  G. Silvestri,et al.  CD4+ CCR5+ T-Cell Dynamics during Simian Immunodeficiency Virus Infection of Chinese Rhesus Macaques , 2007, Journal of Virology.

[18]  J. Zack,et al.  Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+ T Cells , 2007, Journal of Virology.

[19]  Y. Qi,et al.  Polymorphisms in eight host genes associated with control of HIV replication do not mediate elite control of viral replication in SIV-infected Indian rhesus macaques , 2006, Immunogenetics.

[20]  E. Fenyö,et al.  Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome. , 2006, The Journal of general virology.

[21]  S. Lowe,et al.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.

[22]  J. Lifson,et al.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.

[23]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[24]  V. Maino,et al.  Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.

[25]  J. Overbaugh,et al.  Early- and Intermediate-Stage Variants of Simian Immunodeficiency Virus Replicate Efficiently in Cells Lacking CCR5 , 2003, Journal of Virology.

[26]  M. Lederman,et al.  CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro. , 2003, Clinical immunology.

[27]  J. Goedert,et al.  Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection , 2003, AIDS.

[28]  J. Clot,et al.  Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Z. Grossman,et al.  HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.

[30]  M. Malim,et al.  Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4 , 2001, Journal of Virology.

[31]  K. Mansfield,et al.  Dynamics of CCR5 Expression by CD4+ T Cells in Lymphoid Tissues during Simian Immunodeficiency Virus Infection , 2000, Journal of Virology.

[32]  E. Butcher,et al.  The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse1 , 2000, The Journal of Immunology.

[33]  R. Doms,et al.  Multiple nonfunctional alleles of CCR5 are frequent in various human populations. , 2000, Blood.

[34]  R. Doms,et al.  Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. , 2000, Blood.

[35]  R. Doms,et al.  Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL33 for Efficient Entry , 2000, Journal of Virology.

[36]  F. Kirchhoff,et al.  Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. , 1999, The Journal of infectious diseases.

[37]  E. De Clercq,et al.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. , 1999, The Journal of clinical investigation.

[38]  F. Kirchhoff,et al.  Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. , 1999, Journal of General Virology.

[39]  Takayuki Itoh,et al.  Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates , 1999, Journal of Virology.

[40]  D. Ho,et al.  Natural Infection of a Homozygous Δ24 CCR5 Red-capped Mangabey with an R2b-Tropic Simian Immunodeficiency Virus , 1998, The Journal of experimental medicine.

[41]  R. Doms,et al.  Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. , 1998, Virology.

[42]  R. Lal,et al.  Adaptation to promiscuous usage of CC and CXC‐chemokine coreceptors in vivo correlates with HIV‐1 disease progression , 1998, AIDS.

[43]  E. Fenyö,et al.  In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression , 1997, Nature Medicine.

[44]  R. Doms,et al.  CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. , 1997, The Journal of infectious diseases.

[45]  B. Levine,et al.  Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. , 1997, Science.

[46]  R. Doms,et al.  Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation , 1997, Journal of virology.

[47]  R. Koup,et al.  Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1 , 1996, Journal of virology.

[48]  R. Steinman,et al.  Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors , 1996, The Journal of experimental medicine.

[49]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[50]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[51]  Bruce L. Levine,et al.  Antiviral Effect and Ex Vivo CD4+ T Cell Proliferation in HIV-Positive Patients as a Result of CD28 Costimulation , 1996, Science.

[52]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[53]  David A. Williams,et al.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells , 1996, Nature Medicine.

[54]  N. Pedersen,et al.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. , 1990, Science.

[55]  D. Weissman,et al.  Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk , 1997, Molecular medicine.